Richard M Martin1, Rita Patel, Michael S Kramer, Konstantin Vilchuck, Natalia Bogdanovich, Natalia Sergeichick, Nina Gusina, Ying Foo, Tom Palmer, Jennifer Thompson, Matthew W Gillman, George Davey Smith, Emily Oken. 1. School of Social and Community Medicine, University of Bristol, Bristol, UK (R.M.M., R.P., Y.F., G.D.S.); Medical Research Council/University of Bristol Integrated Epidemiology Unit, University of Bristol, Bristol, UK (R.M.M., G.D.S.); National Institute for Health Research, Bristol Biomedical Research Unit in Nutrition, Bristol, UK (R.M.M.); Departments of Pediatrics and of Epidemiology, Biostatistics, and Occupational Health, McGill University Faculty of Medicine, Montreal, Canada (M.S.K.); National Research and Applied Medicine Mother and Child Centre, Minsk, Belarus (K.V., N.B., N.S., N.G.); Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK (T.P.); and Obesity Prevention Program, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA (J.T., M.W.G., E.O.).
Abstract
BACKGROUND: The duration and exclusivity of breastfeeding in infancy have been inversely associated with future cardiometabolic risk. We investigated the effects of an experimental intervention to promote increased duration of exclusive breastfeeding on cardiometabolic risk factors in childhood. METHODS AND RESULTS: We followed-up children in the Promotion of Breastfeeding Intervention Trial, a cluster-randomized trial of a breastfeeding promotion intervention based on the World Health Organization/United Nations Children's Fund Baby-Friendly Hospital Initiative. In 1996 to 1997, 17 046 breastfeeding mother-infant pairs were enrolled from 31 Belarusian maternity hospitals and affiliated polyclinics (16 intervention versus 15 control sites); 13 879 (81.4%) children were followed up at 11.5 years, with 13 616 (79.9%) who had fasted and did not have diabetes mellitus. The outcomes were blood pressure; fasting insulin, adiponectin, glucose, and apolipoprotein A1; and the presence of metabolic syndrome. Analysis was by intention to treat, accounting for clustering within hospitals/clinics. The intervention substantially increased breastfeeding duration and exclusivity in comparison with the control arm (43% versus 6% and 7.9% versus 0.6% exclusively breastfed at 3 and 6 months, respectively). Cluster-adjusted mean differences at 11.5 years between experimental versus control groups were as follows: 1.0 mm Hg (95% confidence interval, -1.1 to 3.1) for systolic and 0.8 mm Hg (-0.6 to 2.3) for diastolic blood pressure; -0.1 mmol/L (-0.2 to 0.1) for glucose; 8% (-3% to 34%) for insulin; -0.3 μg/mL (-1.5 to 0.9) for adiponectin; and 0.0 g/L (-0.1 to 0.1) for apolipoprotein A1. The cluster-adjusted odds ratio for metabolic syndrome, comparing experimental versus control groups, was 1.21 (0.85 to 1.72). CONCLUSIONS: An intervention to improve breastfeeding duration and exclusivity among healthy term infants did not influence cardiometabolic risk factors in childhood. CLINICAL TRIAL REGISTRATION: Current Controlled Trials: ISRCTN37687716 (http://www.controlled-trials.com/ISRCTN37687716). URL: http://clinicaltrials.gov. Unique identifier: NCT01561612.
BACKGROUND: The duration and exclusivity of breastfeeding in infancy have been inversely associated with future cardiometabolic risk. We investigated the effects of an experimental intervention to promote increased duration of exclusive breastfeeding on cardiometabolic risk factors in childhood. METHODS AND RESULTS: We followed-up children in the Promotion of Breastfeeding Intervention Trial, a cluster-randomized trial of a breastfeeding promotion intervention based on the World Health Organization/United Nations Children's Fund Baby-Friendly Hospital Initiative. In 1996 to 1997, 17 046 breastfeeding mother-infant pairs were enrolled from 31 Belarusian maternity hospitals and affiliated polyclinics (16 intervention versus 15 control sites); 13 879 (81.4%) children were followed up at 11.5 years, with 13 616 (79.9%) who had fasted and did not have diabetes mellitus. The outcomes were blood pressure; fasting insulin, adiponectin, glucose, and apolipoprotein A1; and the presence of metabolic syndrome. Analysis was by intention to treat, accounting for clustering within hospitals/clinics. The intervention substantially increased breastfeeding duration and exclusivity in comparison with the control arm (43% versus 6% and 7.9% versus 0.6% exclusively breastfed at 3 and 6 months, respectively). Cluster-adjusted mean differences at 11.5 years between experimental versus control groups were as follows: 1.0 mm Hg (95% confidence interval, -1.1 to 3.1) for systolic and 0.8 mm Hg (-0.6 to 2.3) for diastolic blood pressure; -0.1 mmol/L (-0.2 to 0.1) for glucose; 8% (-3% to 34%) for insulin; -0.3 μg/mL (-1.5 to 0.9) for adiponectin; and 0.0 g/L (-0.1 to 0.1) for apolipoprotein A1. The cluster-adjusted odds ratio for metabolic syndrome, comparing experimental versus control groups, was 1.21 (0.85 to 1.72). CONCLUSIONS: An intervention to improve breastfeeding duration and exclusivity among healthy term infants did not influence cardiometabolic risk factors in childhood. CLINICAL TRIAL REGISTRATION: Current Controlled Trials: ISRCTN37687716 (http://www.controlled-trials.com/ISRCTN37687716). URL: http://clinicaltrials.gov. Unique identifier: NCT01561612.
Authors: Richard M Martin; George Davey Smith; Punam Mangtani; Kate Tilling; Stephen Frankel; David Gunnell Journal: Eur Heart J Date: 2004-05 Impact factor: 29.983
Authors: Rita Patel; Emily Oken; Natalia Bogdanovich; Lidia Matush; Zinaida Sevkovskaya; Beverley Chalmers; Ellen D Hodnett; Konstantin Vilchuck; Michael S Kramer; Richard M Martin Journal: Int J Epidemiol Date: 2013-03-07 Impact factor: 7.196
Authors: David E Laaksonen; Hanna-Maaria Lakka; Leo K Niskanen; George A Kaplan; Jukka T Salonen; Timo A Lakka Journal: Am J Epidemiol Date: 2002-12-01 Impact factor: 4.897
Authors: Tom M Palmer; Jonathan A C Sterne; Roger M Harbord; Debbie A Lawlor; Nuala A Sheehan; Sha Meng; Raquel Granell; George Davey Smith; Vanessa Didelez Journal: Am J Epidemiol Date: 2011-05-09 Impact factor: 4.897
Authors: Richard M Martin; Rita Patel; Emily Oken; Jennifer Thompson; Alexander Zinovik; Michael S Kramer; Konstantin Vilchuck; Natalia Bogdanovich; Natalia Sergeichick; Ying Foo; Nina Gusina Journal: PLoS One Date: 2013-08-01 Impact factor: 3.240
Authors: Lai Ling Hui; Man Ki Kwok; E Anthony S Nelson; So Lun Lee; Gabriel M Leung; C Mary Schooling Journal: Matern Child Nutr Date: 2017-08-04 Impact factor: 3.092
Authors: Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner Journal: Circulation Date: 2017-01-25 Impact factor: 29.690
Authors: Eliana M Perrin; Russell L Rothman; Lee M Sanders; Asheley C Skinner; Svetlana K Eden; Ayumi Shintani; Elizabeth M Throop; H Shonna Yin Journal: Pediatrics Date: 2014-03-17 Impact factor: 7.124
Authors: Olukunmi O Balogun; Elizabeth J O'Sullivan; Alison McFadden; Erika Ota; Anna Gavine; Christine D Garner; Mary J Renfrew; Stephen MacGillivray Journal: Cochrane Database Syst Rev Date: 2016-11-09
Authors: Xun Zhang; Richard M Martin; Emily Oken; Izzuddin M Aris; Seungmi Yang; Michael S Kramer Journal: Am J Epidemiol Date: 2020-04-02 Impact factor: 4.897
Authors: Alison McFadden; Anna Gavine; Mary J Renfrew; Angela Wade; Phyll Buchanan; Jane L Taylor; Emma Veitch; Anne Marie Rennie; Susan A Crowther; Sara Neiman; Stephen MacGillivray Journal: Cochrane Database Syst Rev Date: 2017-02-28
Authors: N S The; C M Shay; A P Lamichhane; T L Crume; J L Crandell; S Wang; D Dabelea; J M Lawrence; E J Mayer-Davis Journal: Diabet Med Date: 2016-10 Impact factor: 4.359